Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chenxiang Qu is a traditional Chinese medicinal (TCM) fermented preparation used to treat gastrointestinal disorders, particularly functional dyspepsia associated with Liver-stomach Disharmony Syndrome. The formulation typically includes Agarwood (*Aquilaria sinensis*) and other herbs that undergo a fermentation process to create a medicated leaven. It is designed to regulate Qi, harmonize the stomach, and alleviate symptoms such as postprandial fullness, early satiety, and epigastric pain. The drug is being evaluated in clinical trials sponsored by Dongfang Hospital Affiliated to Beijing University of Chinese Medicine to establish its efficacy and safety compared to placebo in patients with postprandial discomfort syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chenxiang qu.